Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas.
dc.contributor.author | Ivanov, S | |
dc.contributor.author | Panaccione, A | |
dc.contributor.author | Nonaka, Daisuke | |
dc.contributor.author | Prasad, M | |
dc.contributor.author | Boyd, K | |
dc.contributor.author | Brown, B | |
dc.contributor.author | Guo, Y | |
dc.contributor.author | Sewell, A | |
dc.contributor.author | Yarbrough, W | |
dc.date.accessioned | 2013-09-25T13:38:14Z | |
dc.date.available | 2013-09-25T13:38:14Z | |
dc.date.issued | 2013-07-23 | |
dc.identifier.citation | Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas. 2013, 109 (2):444-51 Br J Cancer | en_GB |
dc.identifier.issn | 1532-1827 | |
dc.identifier.pmid | 23799842 | |
dc.identifier.doi | 10.1038/bjc.2013.326 | |
dc.identifier.uri | http://hdl.handle.net/10541/302281 | |
dc.description.abstract | Salivary adenoid cystic carcinoma (ACC) is an insidious slow-growing cancer with the propensity to recur and metastasise to distant sites. Basal-like breast carcinoma (BBC) is a molecular subtype that constitutes 15-20% of breast cancers, shares histological similarities and basal cell markers with ACC, lacks expression of ER (oestrogen receptor), PR (progesterone receptor), and HER2 (human epidermal growth factor receptor 2), and, similar to ACC, metastasises predominantly to the lung and brain. Both cancers lack targeted therapies owing to poor understanding of their molecular drivers. | |
dc.language.iso | en | en |
dc.rights | Archived with thanks to British journal of cancer | en_GB |
dc.title | Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas. | en |
dc.type | Article | en |
dc.contributor.department | Section of Otolaryngology, Department of Surgery, Yale School of Medicine, 800 Howard Avenue, New Haven, CT 06519-1369, USA. | en_GB |
dc.identifier.journal | British Journal of Cancer | en_GB |
html.description.abstract | Salivary adenoid cystic carcinoma (ACC) is an insidious slow-growing cancer with the propensity to recur and metastasise to distant sites. Basal-like breast carcinoma (BBC) is a molecular subtype that constitutes 15-20% of breast cancers, shares histological similarities and basal cell markers with ACC, lacks expression of ER (oestrogen receptor), PR (progesterone receptor), and HER2 (human epidermal growth factor receptor 2), and, similar to ACC, metastasises predominantly to the lung and brain. Both cancers lack targeted therapies owing to poor understanding of their molecular drivers. |